Advertisement

Cardiovascular Disease Among Adults With Work-Related Asthma, 2012–2017

  • Katelynn E. Dodd
    Correspondence
    Address correspondence to: Katelynn E. Dodd, MPH, Respiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1000 Frederick Lane, MS HG900, Morgantown WV 26508.
    Affiliations
    Respiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention (CDC), Morgantown, West Virginia
    Search for articles by this author
  • David J. Blackley
    Affiliations
    Respiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention (CDC), Morgantown, West Virginia
    Search for articles by this author
  • Jacek M. Mazurek
    Affiliations
    Respiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention (CDC), Morgantown, West Virginia
    Search for articles by this author
Published:November 09, 2022DOI:https://doi.org/10.1016/j.amepre.2022.09.010

      Introduction

      Asthma is associated with an increased risk for cardiovascular disease, and adults with persistent, severe asthma have a significantly higher risk of cardiovascular disease than adults with intermittent or no asthma.

      Methods

      The objective of this cross-sectional study was to assess the association between work-related asthma status and cardiovascular disease among ever-employed adults (aged 18–64 years) with current asthma using data from the 2012–2017 Behavioral Risk Factor Surveillance System Asthma Call-Back Survey from 37 states and the District of Columbia. Weighted prevalence ratios and 95% CIs, adjusted for age, sex, race/ethnicity, education, household income, smoking status, chronic obstructive pulmonary disease, diabetes, and BMI, were calculated. In addition, the associations of cardiovascular disease with adverse asthma outcomes and asthma control among adults with work-related asthma were examined. Analyses were conducted in 2021.

      Results

      Among an estimated annualized 14.8 million ever-employed adults aged 18–64 years with current asthma, adults with work-related asthma (prevalence ratio=1.5; 95% CI=1.2, 1.8) and possible work-related asthma (prevalence ratio=1.2; 95% CI=1.0, 1.5) were significantly more likely to have cardiovascular disease than adults with non-work-related asthma. Among adults with work-related asthma, those with very poorly controlled asthma (prevalence ratio=1.8; 95% CI=1.3, 2.5) and an asthma-related emergency room visit (prevalence ratio=1.5; 95% CI=1.1, 2.0) were significantly more likely to have cardiovascular disease.

      Conclusions

      Adults with work-related asthma were more likely to have cardiovascular disease than those with non-work-related asthma. Primary prevention, early diagnosis, and implementation of optimal work-related asthma management are essential for workers’ health. Cardiovascular disease should be considered where appropriate when diagnosing and recommending treatment and interventions for adults with work-related asthma.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Global Initiative for Asthma (GINA)
        Global strategy for asthma management and prevention updated 2017.
        Global Initiative for Asthma (GINA), Fontana-on-Geneva Lake, WI2019 (Published AprilAccessed March 18, 2021)
        • National Asthma Education and Prevention Program
        Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007 [published correction appears in J Allergy Clin Immunol. 2008;121(6):1330].
        J Allergy Clin Immunol. 2007; 120 (suppl): S94-S138https://doi.org/10.1016/j.jaci.2007.09.043
      1. Most recent national asthma data.
        Centers for Disease Control and Prevention, 2021 (Updated March 30, 2021. Accessed April 17, 2021)
        • Nurmagambetov T
        • Kuwahara R
        • Garbe P.
        The economic burden of asthma in the United States, 2008–2013.
        Ann Am Thorac Soc. 2018; 15: 348-356https://doi.org/10.1513/AnnalsATS.201703-259OC
        • Tarlo SM
        • Balmes J
        • Balkissoon R
        • et al.
        Diagnosis and management of work-related asthma: American College of Chest Physicians Consensus Statement [published correction appears in Chest. 2008;134(4):892].
        Chest. 2008; 134 (suppl): 1S-41Shttps://doi.org/10.1378/chest.08-0201
        • Blanc PD
        • Annesi-Maesano I
        • Balmes JR
        • et al.
        The occupational burden of nonmalignant respiratory diseases. An official American Thoracic Society and European Respiratory Society statement.
        Am J Respir Crit Care Med. 2019; 199: 1312-1334https://doi.org/10.1164/rccm.201904-0717ST
        • Henneberger PK
        • Redlich CA
        • Callahan DB
        An official American Thoracic Society statement: work-exacerbated asthma.
        Am J Respir Crit Care Med. 2011; 184: 368-378https://doi.org/10.1164/rccm.812011ST
        • Knoeller GE
        • Mazurek JM
        • Moorman JE.
        Characteristics associated with health care professional diagnosis of work-related asthma among individuals who describe their asthma as being caused or made worse by workplace exposures.
        J Occup Environ Med. 2012; 54: 485-490https://doi.org/10.1097/JOM.0b013e3182479f93
        • Dodd KE
        • Mazurek JM.
        Asthma medication use among adults with current asthma by work-related asthma status, Asthma Call-back Survey, 29 states, 2012–2013.
        J Asthma. 2018; 55: 364-372https://doi.org/10.1080/02770903.2017.1339245
        • White GE
        • Mazurek JM
        • Moorman JE.
        Work-related asthma and employment status–38 states and District of Columbia, 2006–2009.
        J Asthma. 2013; 50: 954-959https://doi.org/10.3109/02770903.2013.829491
        • Vandenplas O
        • Toren K
        • Blanc PD.
        Health and socioeconomic impact of work-related asthma.
        Eur Respir J. 2003; 22: 689-697https://doi.org/10.1183/09031936.03.00053203
        • Vandenplas O.
        Socioeconomic impact of work-related asthma.
        Expert Rev Pharmacoecon Outcomes Res. 2008; 8: 395-400https://doi.org/10.1586/14737167.8.4.395
        • Knoeller GE
        • Mazurek JM
        • Moorman JE.
        Health-related quality of life among adults with work-related asthma in the United States.
        Qual Life Res. 2013; 22: 771-780https://doi.org/10.1007/s11136-012-0206-7
        • Tattersall MC
        • Guo M
        • Korcarz CE
        • et al.
        Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis.
        Arterioscler Thromb Vasc Biol. 2015; 35: 1520-1525https://doi.org/10.1161/ATVBAHA.115.305452
        • Hansson GK.
        Inflammation, atherosclerosis, and coronary artery disease.
        N Engl J Med. 2005; 352: 1685-1695https://doi.org/10.1056/NEJMra043430
        • Prosser R
        • Carleton B
        • Smith A.
        The comorbidity burden of the treated asthma patient population in British Columbia.
        Chronic Dis Can. 2010; 30: 46-55https://doi.org/10.24095/hpcdp.30.2.03
        • Iribarren C
        • Tolstykh IV
        • Miller MK
        • Sobel E
        • Eisner MD.
        Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts.
        Am J Epidemiol. 2012; 176: 1014-1024https://doi.org/10.1093/aje/kws181
        • Pollevick ME
        • Xu KY
        • Mhango G
        The relationship between asthma and cardiovascular disease: an examination of the Framingham offspring study.
        Chest. 2021; 159: 1338-1345https://doi.org/10.1016/j.chest.2020.11.053
        • Bang DW
        • Wi CI
        • Kim EN
        • et al.
        Asthma status and risk of incident myocardial infarction: a population-based case-control study.
        J Allergy Clin Immunol Pract. 2016; 4: 917-923https://doi.org/10.1016/j.jaip.2016.02.018
        • Heron M.
        Deaths: leading causes for 2017.
        Natl Vital Stat Rep. 2019; 68 (Accessed March 18, 2021): 1-77
        • Guo J
        • Zhang Y
        • Liu T
        • Levy BD
        • Libby P
        • Shi GP.
        Allergic asthma is a risk factor for human cardiovascular diseases.
        Nat CardioVasc Res. 2022; 1: 417-430https://doi.org/10.1038/s44161-022-00067-z
        • Aiello RJ
        • Bourassa PA
        • Lindsey S
        • Weng W
        • Freeman A
        • Showell HJ.
        Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice.
        Arterioscler Thromb Vasc Biol. 2002; 22: 443-449https://doi.org/10.1161/hq0302.105593
        • Spanbroek R
        • Grabner R
        • Lotzer K
        • et al.
        Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis.
        Proc Natl Acad Sci U S A. 2003; 100: 1238-1243https://doi.org/10.1073/pnas.242716099
        • Cepelis A
        • Brumpton BM
        • Laugsand LE
        • et al.
        Asthma, asthma control and risk of acute myocardial infarction: HUNT study.
        Eur J Epidemiol. 2019; 34: 967-977https://doi.org/10.1007/s10654-019-00562-x
        • Bulka CM
        • Daviglus ML
        • Persky VW
        Association of occupational exposures with cardiovascular disease among U.S. Hispanics/Latinos.
        Heart. 2019; 105: 439-448https://doi.org/10.1136/heartjnl-2018-313463
        • Montani D
        • Lau EM
        • Descatha A
        • et al.
        Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease.
        Eur Respir J. 2015; 46: 1721-1731https://doi.org/10.1183/13993003.00814-2015
        • Baur X
        • Bakehe P
        • Vellguth H.
        Bronchial asthma and COPD due to irritants in the workplace–an evidence-based approach.
        J Occup Med Toxicol. 2012; 7: 19https://doi.org/10.1186/1745-6673-7-19
        • Rosenman KD
        • Beckett WS.
        Web based listing of agents associated with new onset work-related asthma.
        Respir Med. 2015; 109: 625-631https://doi.org/10.1016/j.rmed.2015.03.004
      2. Behavioral risk factor surveillance system.
        Centers for Disease Control and Prevention (CDC), 2020 (Updated August 31, 2020. Accessed March 18, 2021)
      3. BRFSS Asthma Call-Back Survey.
        Centers for Disease Control and Prevention (CDC), 2021 (Updated February 25, 2021. Accessed March 18, 2021)
        • Pierannunzi C
        • Hu SS
        • Balluz L.
        A systematic review of publications assessing reliability and validity of the Behavioral Risk Factor Surveillance System (BRFSS), 2004–2011.
        BMC Med Res Methodol. 2013; 13: 49https://doi.org/10.1186/1471-2288-13-49
        • Knoeller GE
        • Mazurek JM
        • Moorman JE.
        Work-related asthma, financial barriers to asthma care, and adverse asthma outcomes: Asthma Call-Back Survey, 37 states and District of Columbia, 2006 to 2008.
        Med Care. 2011; 49: 1097-1104https://doi.org/10.1097/MLR.0b013e31823639b9
        • Centers for Disease Control and Prevention (CDC)
        Behavioral risk factor surveillance system comparability of data BRFSS 2017.
        Centers for Disease Control and Prevention (CDC), Atlanta, GA2018 (Published July 2018. Accessed March 18, 2021)
        • Hipple SF.
        People who are not in the labor force: why aren’t they working?.
        U.S. Bureau of Labor Statistics, Washington, DC2015 (Published December 30, 2015. Accessed March 18, 2021)
        • Rodgers JL
        • Jones J
        • Bolleddu SI
        • et al.
        Cardiovascular risks associated with gender and aging.
        J Cardiovasc Dev Dis. 2019; 6: 19https://doi.org/10.3390/jcdd6020019
        • Wei L
        • MacDonald TM
        • Walker BR
        Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease.
        Ann Intern Med. 2004; 141: 764-770https://doi.org/10.7326/0003-4819-141-10-200411160-00007
        • Dominguez K
        • Penman-Aguilar A
        • Chang MH
        • et al.
        Vital Signs: leading causes of death, prevalence of diseases and risk factors, and use of health services among Hispanics in the United States–2009-2013 [published correction appears in MMWR Morb Mortal Wkly Rep. 2015;64(40):1153].
        MMWR Morb Mortal Wkly Rep. 2015; 64: 469-478
        • Knoeller GE
        • Mazurek JM
        • Moorman JE.
        Asthma symptoms among adults with work-related asthma.
        J Asthma. 2013; 50: 166-173https://doi.org/10.3109/02770903.2012.754029
        • Bellia V
        • Pedone C
        • Catalano F
        • et al.
        Asthma in the elderly: mortality rate and associated risk factors for mortality.
        Chest. 2007; 132: 1175-1182https://doi.org/10.1378/chest.06-2824
        • Schanen JG
        • Iribarren C
        • Shahar E
        • et al.
        Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study.
        Thorax. 2005; 60: 633-638https://doi.org/10.1136/thx.2004.026484
        • Van Eeden S
        • Leipsic J
        • Paul Man SF
        • Sin DD
        The relationship between lung inflammation and cardiovascular disease.
        Am J Respir Crit Care Med. 2012; 186: 11-16https://doi.org/10.1164/rccm.201203-0455PP
        • Leachi HFL
        • Marziale MHP
        • Martins JT
        • Aroni P
        • Galdino MJQ
        • Ribeiro RP.
        Polycyclic aromatic hydrocarbons and development of respiratory and cardiovascular diseases in workers.
        Rev Bras Enferm. 2020; 73e20180965https://doi.org/10.1590/0034-7167-2018-0965
        • Vandenplas O
        • Dressel H
        • Nowak D
        • Jamart J
        ERS Task Force on the Management of Work-related Asthma. What is the optimal management option for occupational asthma?.
        Eur Respir Rev. 2012; 21: 97-104https://doi.org/10.1183/09059180.00004911
        • Vandenplas O
        • Dressel H
        • Wilken D
        • et al.
        Management of occupational asthma: cessation or reduction of exposure? A systematic review of available evidence.
        Eur Respir J. 2011; 38: 804-811https://doi.org/10.1183/09031936.00177510
        • Baur X
        • Sigsgaard T
        • Aasen TB
        • et al.
        Guidelines for the management of work-related asthma [published correction appears in Eur Respir J. 2012;39(6):1553].
        Eur Respir J. 2012; 39: 529-545https://doi.org/10.1183/09031936.00096111
        • Tarlo S.
        Clinical aspects of work-related asthma: past achievements, persistent challenges, and emerging triggers.
        J Occup Environ Med. 2014; 56: S40-S44https://doi.org/10.1097/JOM.0000000000000285
        • Legiest B
        • Nemery B.
        Management of work-related asthma: guidelines and challenges.
        Eur Respir Rev. 2012; 21: 79-81https://doi.org/10.1183/09059180.00002912
        • Mazurek JM
        • White GE
        • Moorman JE
        • Storey E.
        Patient-physician communication about work-related asthma: what we do and do not know.
        Ann Allergy Asthma Immunol. 2015; 114: 97-102https://doi.org/10.1016/j.anai.2014.10.022
        • National Academies of Sciences Engineering, and Medicine
        A Smarter National Surveillance System for Occupational Safety and Health in the 21st Century.
        National Academies Press (U.S.), Washington, DC2018https://doi.org/10.17226/24835
        • Jenkins MA
        • Clarke JR
        • Carlin JB
        • et al.
        Validation of questionnaire and bronchial hyperresponsiveness against respiratory physician assessment in the diagnosis of asthma.
        Int J Epidemiol. 1996; 25: 609-616https://doi.org/10.1093/ije/25.3.609
        • Barr EL
        • Tonkin AM
        • Welborn TA
        • Shaw JE.
        Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: the AusDiab study.
        Intern Med J. 2009; 39: 49-53https://doi.org/10.1111/j.1445-5994.2008.01864.x
        • Sama SR
        • Hunt PR
        • Cirillo CI
        • et al.
        A longitudinal study of adult-onset asthma incidence among HMO members.
        Environ Health. 2003; 2: 10https://doi.org/10.1186/1476-069X-2-10